Acura Pharmaceuticals

Acura Pharmaceuticals es una empresa que cotiza bajo el símbolo de cotización ACUR (US).

Ver el organigrama con sus 11 ejecutivos principales

Biografías más buscadas en Acura Pharmaceuticals

• Robert Jones, President, Chief Executive Officer and Director
• George Ross, Director
• Immanuel Thangaraj, Director

Crear su alerta
para seguir los movimientos de los ejecutivos en Acura Pharmaceuticals.

Acura Pharmaceuticals tiene 1.828 competidores entre los que se incluyen Pfizer (Estados Unidos), Johnson & Johnson (Estados Unidos) y Sanofi (Francia).

Popular M&A news in Farmacia

• Revance Therapeutics has announced the acquisition of Revance Therapeutics  (publicado el 14 de enero de 2025).
• Stemtech and Seacret Direct have announced they will merge  (publicado el 5 de diciembre de 2024)..
• Recursion Pharma and Exscientia have merged  (publicado el 27 de noviembre de 2024)..

Otros contactos sugeridos en el sector Farmacia

• Kristin Berkinsky - Chief Human Resources Officer en Adare Pharmaceuticals
• Paul Meister - Chairman of the Board en Amneal Pharmaceuticals
• Seth Harrison - Chairman and Director en Braeburn Pharmaceuticals

Saber más sobre el sector Farmacia >

Últimos comunicados de prensa de Acura Pharmaceuticals

• LinkedIn Login, Sign in | LinkedIn
• https://twitter.com/intent/tweet?status=Acura%20Pharmaceuticals,%20Inc.%20-%20Press%20Releases+http%3A%2F%2Finvestors.acurapharm.com%2Fpress-releases
• RSS News Feeds | Acura Pharmaceuticals, Inc.
• Acura Pharmaceuticals Announces Second Quarter 2020 Financial Results | Acura Pharmaceuticals, Inc.
• Acura Pharmaceuticals Announces First Quarter 2020 Financial Results | Acura Pharmaceuticals, Inc.
• Acura Pharmaceuticals Announces Fourth Quarter and Full Year 2019 Financial Results | Acura Pharmaceuticals, Inc.
• Acura Pharmaceuticals Provides an Update on the Development of LTX-03 | Acura Pharmaceuticals, Inc.
• Acura Pharmaceuticals Announces Third Quarter 2019 Financial Results | Acura Pharmaceuticals, Inc.
• Acura Pharmaceuticals Announces Second Quarter 2019 Financial Results | Acura Pharmaceuticals, Inc.
• Acura Pharmaceuticals Provides an Update on the Development of LTX-03 | Acura Pharmaceuticals, Inc.
• View more press releases Close

Redes sociales sobre Acura Pharmaceuticals

• Acura Pharmaceuticals en Wikipedia, Google News y Yahoo Finance
• Acura Pharmaceuticals en LinkedIn, Twitter y YouTube

Contactar a través de e-mail con sus ejecutivos Peter Clemens

Llame a Acura Pharmaceuticals al +1 847...

Ver el organigrama

Register to receive your alert

Señalar un error